NCT05823051

Brief Summary

Sudden Infant Death Syndrome (SIDS) is one of the leading causes of infant mortality in the postneonatal period, but it can be prevented and its incidence can be reduced by creating a safe sleep environment with modifiable risk factors. It is known that parents, infant care providers and healthcare professionals do not have sufficient knowledge about SIDS and safe sleep, and especially mothers exhibit many risky behaviors in terms of SIDS, such as using the wrong sleeping positions while putting their babies to sleep. Therefore, it is of critical importance to inform and raise awareness of parents on the issues of SIDS and safe sleep, which remain important today, on the premise of promoting public health.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2023

Completed
Last Updated

April 21, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

April 8, 2023

Last Update Submit

April 8, 2023

Conditions

Keywords

Sudden Infant Death SyndromeNursingParent EducationEducational ProgramPrevention

Outcome Measures

Primary Outcomes (4)

  • Sudden Infant Death Syndrome Knowledge Level Assessment Form 1

    This form was developed by the researchers in line with the literature and consists of 33 items to measure the level of knowledge about SIDS.

    Before the training

  • Sudden Infant Death Syndrome Knowledge Level Assessment Form 2

    This form was developed by the researchers in line with the literature and consists of 33 items to measure the level of knowledge about SIDS.

    1 month after the training

  • General Self-Efficacy Scale 1

    "General Self-Efficacy Scale" is a five-point Likert-type scale consisting of 17 items. The question "How well does it describe you?" has five options ranging from "not at all" to "very well". The total score of the scale ranges between 17-85, and the higher the score, the higher the self-efficacy belief.

    Before the training

  • General Self-Efficacy Scale 2

    "General Self-Efficacy Scale" is a five-point Likert-type scale consisting of 17 items. The question "How well does it describe you?" has five options ranging from "not at all" to "very well". The total score of the scale ranges between 17-85, and the higher the score, the higher the self-efficacy belief.

    1 month after the training

Secondary Outcomes (3)

  • Personal Information Form

    Before the training

  • DISCERN Scale

    After the training videos are created

  • System Usability Scale (SUS)

    Pre-application

Study Arms (2)

VASIDS-TP and Counseling Practice

EXPERIMENTAL

Video-Assisted Sudden Infant Death Syndrome Prevention Training Program (VASIDS-TP) and Counseling Practice

Other: VASIDS-TP and Counseling Practice

Routine Care

NO INTERVENTION

The control group will receive routine care in the obstetric ward. A pre-test will be conducted using the Google Survey form. "Personal Information Form", "Sudden Infant Death Syndrome Knowledge Level Assessment Form" (Pre-Test) and "General Self-Efficacy Scale" will be completed at this stage. The mothers in the control group will receive the training included in clinical routine care. The mothers in this group will not receive any planned structured training by the researchers during the study. The mothers in the control group will be administered the "Sudden Infant Death Syndrome Knowledge Level Assessment Data Form" and the "General Self-Efficacy Scale" with the Google survey that will be sent to their phones 1 month after the pre-test application. After the completion of the study, the control group will receive the same intervention (VASIDS-TP) as the intervention group.

Interventions

VASIDS-TP will be implemented online as an individual training to the intervention group through the Microsoft Teams program, to be completed in 5 days-5 sessions in the time frames determined by the participants. The consultancy practice will start with a pre-test and participants will be assured that they can call the researcher 24/7, and the consultancy practice will be continued by phone call or messaging.

VASIDS-TP and Counseling Practice

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen who have just given birth
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The one who has just given birth,
  • With a healthy newborn baby,
  • Speaks, understands and can read and write Turkish and has no barriers to communication,
  • Able to use the internet, telephone and e-mail actively,
  • Mothers who voluntarily agreed to participate in the study will be included.

You may not qualify if:

  • Have not attended at least 3 sessions of the training program,
  • Mothers who indicate that they want to leave the study while the research is ongoing will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hutton JS, Gupta R, Gruber R, Berndsen J, DeWitt T, Ollberding NJ, Van Ginkel JB, Ammerman RT. Randomized Trial of a Children's Book Versus Brochures for Safe Sleep Knowledge and Adherence in a High-Risk Population. Acad Pediatr. 2017 Nov-Dec;17(8):879-886. doi: 10.1016/j.acap.2017.04.018. Epub 2017 Apr 24.

    PMID: 28450082BACKGROUND

MeSH Terms

Conditions

Sudden Infant Death

Condition Hierarchy (Ancestors)

Death, SuddenDeathPathologic ProcessesPathological Conditions, Signs and SymptomsInfant Death

Central Study Contacts

Dilara AYDIN TOZLU, Master's degree

CONTACT

Emine EFE, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
As a randomization method, "simple randomization method" will be used to ensure an equal number of samples in the two groups and to prevent bias. In addition, during the data analysis phase, the database will be created by an academician independent of the researcher providing the training.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study was planned as a randomized controlled, parallel, double centered and double blind study.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

April 8, 2023

First Posted

April 21, 2023

Study Start

July 1, 2023

Primary Completion

October 15, 2023

Study Completion

November 15, 2023

Last Updated

April 21, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share